Search research articles
Contact Us
Filters
Showing results (861-870 of 874) with videos related to
Page
of 88
Sort By:
Cancer
|
September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Talha Badar, Parameswaran Hari, Omar Dávila, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
British Journal of Haematology
|
March 16, 2021
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Laura Rosiñol, Meral Beksac, Elena Zamagni, et al.
Leukemia
|
January 5, 2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C Fernández de Larrea, R A Kyle, B G M Durie, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Blood Advances
|
February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Journal of the American College of Radiology : JACR
|
February 6, 2026
Recommendations From the Blue Ribbon Panel on Fluoroscopy Safety
Dustin A Gress, M Mahesh, Kevin W Dickey, et al.
Page
of 88
Search research articles
Search
Showing results (861-870 of 874) with videos related to
Sort By:
Page
of 88
Cancer
|
September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Talha Badar, Parameswaran Hari, Omar Dávila, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
British Journal of Haematology
|
March 16, 2021
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Laura Rosiñol, Meral Beksac, Elena Zamagni, et al.
Leukemia
|
January 5, 2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C Fernández de Larrea, R A Kyle, B G M Durie, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Blood Advances
|
February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Journal of the American College of Radiology : JACR
|
February 6, 2026
Recommendations From the Blue Ribbon Panel on Fluoroscopy Safety
Dustin A Gress, M Mahesh, Kevin W Dickey, et al.
Page
of 88